Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?

Stefano Christian Londero, Christian Godballe, Annelise Krogdahl, Lars Bastholt, Lena Specht, Christian Hjort Sørensen, Henrik Baymler Pedersen, Ulrik Pedersen, Peer Christiansen

Research output: Contribution to journalJournal articleResearchpeer-review

15 Citations (Scopus)

Abstract

Papillary microcarcinomas (PMC) of the thyroid gland are defined according to The WHO Committee as papillary carcinomas measuring 10 mm or less in diameter. A large proportion of these tumours are found coincidentally in the treatment of symptomatic goitre and most cases follow an indolent course with an excellent prognosis. However, a more aggressive behaviour with regional and distant metastases does occur. The aim of this study was to evaluate if the immunohistochemical markers cyclin D1 or galectin-3 might indicate the presence of metastatic disease in patients with PMC at the time of diagnosis.
Original languageEnglish
JournalActa Oncologica
Volume47
Pages (from-to)451-7
Number of pages7
ISSN0284-186X
DOIs
Publication statusPublished - 2008
Externally publishedYes

Keywords

  • Adult
  • Carcinoma, Papillary
  • Cyclin D
  • Cyclins
  • Databases, Factual
  • Denmark
  • Female
  • Galectin 3
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Proteins
  • Thyroid Neoplasms
  • Tumor Markers, Biological

Fingerprint

Dive into the research topics of 'Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?'. Together they form a unique fingerprint.

Cite this